NASDAQ:IMGO - Nasdaq - US45250K1079 - Common Stock - Currency: USD
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.
Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently reported that it has 1.00 million shares sold short, which is 3.97% of all regular shares that are available for trading.
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Merck (MRK) shareholders have much to celebrate as the company is the best performing large US pharma of 2022 with a return of more than 43% this year.One of the Merck's (MRK)...
REDWOOD CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago” or the “Company”) (Nasdaq: IMGO), a clinical-stage...
- 100% of patients treated with bomedemstat for ≥24 weeks (n=62 as of October 18, 2022) achieved a platelet count in the normal range with a median time to...
- As of the data cutoff of 18 October 2022, bomedemstat demonstrated spleen volume reduction in 66% (33/50) of patients and reduction in total symptom...
Mentions: MRK
REDWOOD CITY, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company...
The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Imago BioSciences, Inc....
Mentions: MRK
/PRNewswire/ -- Ademi LLP is investigating Imago (Nasdaq: IMGO) for possible breaches of fiduciary duty and other violations of law in its transaction with...